معرفی
Nicoleta Economou-Zavlanos, PhD, serves as Assistant Professor of Biostatistics & Bioinformatics at Duke University School of Medicine, where she directs the Duke Health AI Evaluation & Governance Program and founded the Algorithm-Based Clinical Decision Support (ABCDS) Oversight initiative. She holds leadership roles on the NIH Common Fund’s Bridge to Artificial Intelligence (Bridge2AI) Executive Committee and previously advised the Coalition for Health AI (CHAI) from 2024-2025 as Scientific Advisor.
Her academic foundation includes a Ph.D. from Drexel University (2012).
- Ph.D., Drexel University (2012)
Dr. Economou-Zavlanos pioneers frameworks for health AI governance, focusing on regulatory science, bias mitigation, and ethical deployment of clinical AI systems. Her research bridges technical development with real-world implementation, emphasizing health equity and clinician-AI collaboration. She has established herself as a national authority in developing assurance standards for AI in healthcare through initiatives like ABCDS Oversight.
Analysis of her 31 publications (10 most recent shown) reveals consistent thematic focus on governance infrastructure, bias identification in clinical models, and human-AI collaboration frameworks. Her work spans high-impact journals including NPJ Digital Medicine, JAMA, and JAMIA, demonstrating interdisciplinary rigor across biomedical informatics, regulatory science, and clinical ethics.
Scientific awards were not explicitly referenced in source materials.
Her grant portfolio demonstrates significant research leadership:
- Measuring AI Maturity in Healthcare Organizations (Vanderbilt University Medical Center, 2023-2026)
- Health AI Coalition Workgroup (Mitre Corporation, 2022)
- Enhanced X-ray Angiography Analysis Using Deep Learning (Vigilant Medical, 2019-2022)
She actively mentors through Duke’s AI Health programs and professional initiatives, though specific advisees aren’t listed. Her leadership extends to 35+ professional engagements including HLTH Europe 2024 keynotes and CMS advisory sessions.
As head of Duke’s AI Evaluation & Governance Program and ABCDS Oversight, she operates at the nexus of technical innovation and clinical implementation, driving development of practical frameworks for AI assurance across healthcare systems.
